scPharmaceuticals Inc (FRA:2SX)
€ 3.34 -0.12 (-3.47%) Market Cap: 176.08 Mil Enterprise Value: 139.10 Mil PE Ratio: 0 PB Ratio: 6.04 GF Score: 28/100

scPharmaceuticals Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 03:30PM GMT
Release Date Price: €7.1 (+2.16%)
Ken Cacciatore
Cowen & Company, LLC - Analyst

Thanks, John and Steve, for joining us. It is great to have you here. I'm not sure we had you present ever in the past, but you and I have known each other now -- I'm thinking about this -- eight years? It's got to be eight or nine years.

John Tucker
scPharmaceuticals Inc. - President & CEO

Eight years, Ken.

Ken Cacciatore
Cowen & Company, LLC - Analyst

Which I think is a good place to start because we started doing diligence about eight or nine years ago when we first met. I think oftentimes when you think about development and there's kind of fits and starts, we can look at that negatively. But we can also kind of talk about the positives and kind of what you learned. And for us when we were doing our diligence and one of the things in between those eight or nine years was COVID, which has changed a little bit of the perception and utilization of this.

When we first met, a lot of clinicians said there was a need, but to the extent that they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot